Knowledge Center

Article / Jun 08, 2009

A Well-Integrated Sideline. Deal to supply an inhaler device to Daiichi Sankyo marks a big victory for Hovione

Authors:
Source:
C&EN, 8 June, 2009

Spirits were high as Portugal-based executives from Hovione arrived in Cork, Ireland, in late April for the inauguration of the company's newly acquired pharmaceutical chemical facility. The acquisition, from Pfizer, closed on April 8, the same day as the company's 50th anniversary.

Related links

Read article here

Also in the Knowledge Center

Related Content

Corticosteroids

Corticosteroids are produced in two dedicated buildings on the Loures site, which are equipped with vessels ranging from 50L up to 4000L.

Page
Read more

Drug Product Development

Leveraging our expertise particle engineering, Hovione can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more

API

Hovione inhalation grade APIs bring unique controlled performance to your formulation.

Page
Read more